Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2020-05-15 Regulatory Filings
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-05-15 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a notification addressed to the stock exchange about the outcome of a Board Meeting held on 17th March 2020. It mentions the acceptance of a director's resignation and a deferred agenda item related to share transfer. The content focuses on changes in the company's board and related disclosures. The document is short (1418 characters) and is an announcement rather than a detailed report. Therefore, it fits the category of Board/Management Information (MANG).
2020-03-17 English
Cessation
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 112 characters, indicating it is extremely short and does not contain any report content. It is likely a placeholder or an announcement without actual report data. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings without substantive content.
2020-03-07 English
Board Meeting — Other business matters
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 112 characters, indicating it is extremely short and does not contain any report content. It does not provide any financial statements, management discussion, or regulatory information. Given the lack of content and the presence of only image placeholders, this document is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2020-03-07 English
Reply to Clarification Sought
Board/Management Information Classification · 100% confidence The document is an official communication from Ajooni Biotech Limited to the National Stock Exchange of India regarding the appointment of a new Company Secretary cum Compliance Officer, Ms. Swati Vijan. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013. The content includes a brief profile of the appointee, a certified true copy of the board resolution approving the appointment, and the outcome of the board meeting. There are no financial statements, earnings data, or detailed financial analysis present. The document is primarily an announcement of a management change, specifically the appointment of a key officer. Therefore, it fits the category of Board/Management Information (MANG). The document length (7227 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive disclosure of management change.
2020-02-13 English
Outcome of Board Meeting
Regulatory Filings Classification · 90% confidence The document text is extremely short (58 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement of a report. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2020-02-12 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.